LABORATORY NEWS
-
Zepto Life Technology Earns CAP Accreditation For Clinical Laboratory Offering FungiFlex® Fungal Testing
Zepto Life Technology today announced that its clinical laboratory has received accreditation from the College of American Pathologists (CAP), effective November 14, 2026. The laboratory offers the FungiFlex® menu of targeted plasma cell-free DNA (cfDNA) tests to aid in the diagnosis of invasive fungal infections, with results reported in less than 24 hours after sample receipt.
- Clinisys™ Laboratory Solution v2025.4 Helps Laboratories Go Live Faster And Act Sooner
- Myriad Genetics Expands SRL Partnership In Japan To Support Future Growth
- Labcorp To Expand Clinical Trial Operations In Brazil With Dedicated Kit Assembly And Future Laboratory Operations Through Collaboration With Grupo Fleury
- Roche Receives FDA De Novo Authorization For cobas® pro i 601 platform with Ionify® Gabapentin Assay, Advancing Automated Mass Spectrometry For Routine Clinical Laboratories
ARCHIVED NEWSLETTER
- 10.06.26 -- QIAGEN Launches QIAmini To Automate Small-Batch Sample Preparation
- 09.22.26 -- Sakura Finetek Europe Launches Sakura Pathology Network
- 08.25.26 -- GHK-Cu Peptide Launched By Kylo Peptides For Laboratory Research Applications
- 07.21.26 -- Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
- 07.07.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis